Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
5-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.5.2
advertisement
11.5.2 Topical
(9)
Showing records 1 to 9
Display all abstracts in classification
11.5.2 Topical
Search within classification 11.5.2 Topical
9907
Hypotony and choroidal effusion induced by topical timolol and dorzolamide in patients with previous glaucoma drainage device implantation
Callahan C; Ayyala RS
Ophthalmic Surgery Lasers and Imaging
2003; 34: 467-469
9906
A six-week, parallel, randomized, double-blind study comparing the efficacy and safety of the 0.5% timolol/2.0% MK-507 combination b.i.d. to the concomitant administration of 0.5% timolol b.i.d. and 2.0% MK-507 b.i.d.
Chen YF; Yang CH; Hung PT
Journal of Ocular Pharmacology and Therapeutics
2003; 19: 417-423
9900
A three-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
Coleman AL; Lerner F; Bernstein P; Whitcup SM; Lumigan/Cosopt Study Group
Ophthalmology
2003; 110: 2362-2368
9908
Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices
Pajic B
Current Medical Research and Opinion
2003; 19: 95-101
9933
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors
Abbate F; Casini A; Scozzafava A; Supuran CT
Journal of Enzyme Inhibition and Medicinal Chemistry
2003; 18: 303-308
9885
Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients
Arend O; Harris A; Wolter P; Remky A
Acta Ophthalmologica Scandinavica
2003; 81: 474-479
9931
Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide
Casini A; Scozzafava A; Mincione F; Menabuoni L; Starnotti M; Supuran CT
Bioorganic and Medicinal Chemistry Letters
2003; 13: 2867-2873
9932
Brinzolamide: a review of its use in the management of primary open-angle glaucoma and ocular hypertension
Cvetkovic RS; Perry CM
Drugs and Aging
2003; 20: 919-947
9934
Effects of brinzolamide on aqueous humor dynamics in monkeys and rabbits
Toris CB; Zhan GL; McLaughlin MA
Journal of Ocular Pharmacology and Therapeutics
2003; 19: 397-404
Issue
5-3
Table of Contents
Editor's Selection
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement